Claudio Mencacci
Claudio Mencacci
Department of Neuroscience, ASST Fatebenefratelli Sacco, Milan, Italy
Email verificata su - Home page
TitoloCitata daAnno
Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study
A Hale, RM Corral, C Mencacci, JS Ruiz, CA Severo, V Gentil
International clinical psychopharmacology 25 (6), 305-314, 2010
Anti-anxiety efficacy of Sudarshan Kriya Yoga in general anxiety disorder: a multicomponent, yoga based, breath intervention program for patients suffering from generalized …
S Doria, A De Vuono, R Sanlorenzo, F Irtelli, C Mencacci
Journal of affective disorders 184, 310-317, 2015
The risk of new-onset diabetes in antidepressant users–a systematic review and meta-analysis
V Salvi, I Grua, G Cerveri, C Mencacci, F Barone-Adesi
PloS one 12 (7), 2017
Anxiety disorders in pregnancy and the postpartum period
R Anniverno, A Bramante, C Mencacci, F Durbano
New iInsights into anxiety disorders. Rijeka: InTech, 259-85, 2013
Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region …
GL Colombo, E Agabiti-Rosei, A Margonato, C Mencacci, CM Montecucco, ...
PloS one 8 (12), 2013
Are “social drugs”(tobacco, coffee and chocolate) related to the bipolar spectrum?
I Maremmani, G Perugi, L Rovai, AGI Maremmani, M Pacini, PL Canonico, ...
Journal of affective disorders 133 (1-2), 227-233, 2011
H1-histamine receptor affinity predicts weight gain with antidepressants
V Salvi, C Mencacci, F Barone-Adesi
European Neuropsychopharmacology 26 (10), 1673-1677, 2016
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study
PA Cortesi, C Mencacci, F Luigi, E Pirfo, P Berto, MCJM Sturkenboom, ...
BMC psychiatry 13 (1), 98, 2013
Unexplained somatic symptoms during major depression: prevalence and clinical impact in a national sample of Italian psychiatric outpatients
G Perugi, PL Canonico, P Carbonato, C Mencacci, G Muscettola, L Pani, ...
Psychopathology 44 (2), 116-124, 2011
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
C Mencacci, G Di Sciascio, P Katz, C Ripellino
ClinicoEconomics and outcomes research: CEOR 5, 87, 2013
Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions
A Fattori, L Neri, E Aguglia, A Bellomo, A Bisogno, D Camerino, ...
BioMed research international 2015, 2015
Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients
G Perugi, M Fornaro, I Maremmani, PL Canonico, P Carbonatto, ...
Psychopathology 45 (6), 390-398, 2012
Impact of substitution among generic drugs on persistence and adherence: a retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy
GL Colombo, E Agabiti-Rosei, A Margonato, C Mencacci, CM Montecucco, ...
Atherosclerosis Supplements 21, 1-8, 2016
Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study
L Degli Esposti, D Sangiorgi, C Mencacci, E Spina, C Pasina, M Alacqua, ...
BMC psychiatry 14 (1), 282, 2014
Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression
E Di Nasso, A Chiesa, A Serretti, D De Ronchi, C Mencacci
Clinical drug investigation 31 (6), 385-405, 2011
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels
LS Volonteri, A Colasanti, G Cerveri, A Fiorentini, IF De Gaspari, ...
Journal of Psychopharmacology 24 (8), 1193-1199, 2010
Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients
LS Volonteri, G Cerveri, IF De Gaspari, ML Baldi, ML Rolandi, P Papa, ...
Psychopharmacology 210 (4), 489-497, 2010
Sudarshan Kriya Yoga improves cardiac autonomic control in patients with anxiety-depression disorders
E Toschi-Dias, E Tobaldini, M Solbiati, G Costantino, R Sanlorenzo, ...
Journal of affective disorders 214, 74-80, 2017
Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: interim results of a randomised, rater-blinded study
E Sacchetti, P Valsecchi, C Regini, A Galluzzo, P Cacciani, E Agrimi, ...
Poster presented at the 16th Congress of the European College of …, 2003
Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders
A Fattori, L Neri, A Bellomo, M Vaggi, C Mencacci, ILDE Study Group
Quality of Life Research 26 (9), 2459-2469, 2017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20